Viewing Study NCT01877694


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-02-25 @ 4:58 PM
Study NCT ID: NCT01877694
Status: COMPLETED
Last Update Posted: 2015-05-28
First Post: 2013-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Sponsor: NovaBay Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module